Cll Treatment Websites
Treatment for Previously Untreated FL - GAZYVA® (obinutuzumab)
GAZYVA® for first-line FL treatment. Learn about GAZYVA mechanism of action, administration and obinutuzumab side effects. Indications: GAZYVA® (obinutuzumab), in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL). GAZYVA® (obinutuzumab
Not Applicable
$
8.95
